Lundbeck, a biopharmaceutical company based in Denmark, has announced the acquisition of Longboard Pharmaceuticals in a ...

For American Tower, average sales revenue over the last 5 years has been $10.93 Billion, so in the context of the Graham ...

The market seems to share this optimistic view, since JD.com has a short interest of only 3.3% (this is the percentage of the ...

UnitedHealth's short interest — meaning the percentage of the share float that is being shorted — is lower than average at ...

L3Harris Technologies (NYSE: LHX) has announced the appointment of David S. Regnery, Chair and CEO of Trane Technologies plc, ...

The company's strategic framework focuses on four foundational areas: assortment, experience, access, and loyalty. Actioning ...

Genmab A/S has a trailing 12 month Price to Earnings (P/E) ratio of 18.4 while the S&P 500 average is 29.3 Its forward ...

BBD has an average analyst rating of buy and is -23.68% away from its mean target price of $3.42 per share Its trailing ...

Teck Resources trades -12.18% away from its average analyst target price of $57.56 per share. The 13 analysts following the ...

Agilent Technologies trades -4.13% away from its average analyst target price of $147.98 per share. The 16 analysts following ...

The primary objective is to evaluate the safety of CLN-978 for the treatment of active moderate to severe SLE, with secondary ...

Morgan Stanley has EPS growth achieved by reducing the number of outstanding shares, positive cash flows, and a highly ...